Your browser doesn't support javascript.
loading
Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor.
Lee, Lauren Y; Hernandez, Daniela; Rajkhowa, Trivikram; Smith, Samuel C; Raman, Jayant Ranganathan; Nguyen, Bao; Small, Donald; Levis, Mark.
Affiliation
  • Lee LY; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Hernandez D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Rajkhowa T; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Smith SC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Raman JR; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Nguyen B; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Small D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
  • Levis M; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
Blood ; 129(2): 257-260, 2017 01 12.
Article in En | MEDLINE | ID: mdl-27908881
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Leukemia, Myeloid, Acute / Fms-Like Tyrosine Kinase 3 / Aniline Compounds Limits: Humans Language: En Journal: Blood Year: 2017 Type: Article Affiliation country: Moldova
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Leukemia, Myeloid, Acute / Fms-Like Tyrosine Kinase 3 / Aniline Compounds Limits: Humans Language: En Journal: Blood Year: 2017 Type: Article Affiliation country: Moldova